Get the latest Science News and Discoveries

Genetically engineering a treatment for incurable brain tumors - EurekAlert


<p>Sandro Matosevic of Purdue University&#39;s College of Pharmacy leads a team developing and validating a patent-pending novel immunotherapy to be used against glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma. Matosevic is also on the faculty of the&nbsp;Purdue Institute for Cancer Research&nbsp;and the&nbsp;Purdue Institute for Drug Discovery. The Matosevic-led research has been published in the peer-reviewed journal&nbsp;Nature Communications.</p>

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of EurekAlert

EurekAlert

Photo of Treatment

Treatment

Related news:

News photo

Online tools can help to lower costs for urologic medications - EurekAlert

News photo

KIER accelerates international cooperation on 'clean energy' with Europe's largest research institute - EurekAlert

News photo

U of T researchers map protein network dynamics during cell division - EurekAlert